Dose‐ and time‐dependent expression of transforming growth factor‐β1 mRNA and protein in mouse epidermis and papillomas after repeated topical application of benzo[a]pyrene
- 1 January 1993
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 8 (4), 264-271
- https://doi.org/10.1002/mc.2940080409
Abstract
Topical weekly application of 64 μg of benzo[a]pyrene (BAP) for 4 wk induced transforming growth factor (TGF)-β1 mRNA in the epidermis of Swiss (ICR) mice, with a maximum at 6–12 h after the last treatment. The increase in TGF-β1 mRNA concentration was accompanied by an increase in immunohistochemically detectable intracellularly localized TGF-β1 protein in the suprabasal epidermis and by the appearance of extracellularly localized TGF-β1 in the basal layers. A dose rate of 16 μg/wk for 4 wk was unable to induce the same response. In contrast, after 20 weekly topical applications of 16 or 64 μg of BAP, an increase in TGF-β1 mRNA concentration and the appearance of extracellularly localized protein in the epidermis were observed. These changes in TGF-β1 expression were paralleled by changes in epidermal morphology. A similar group of animals treated with 4 μg of BAP/wk for 20 wk did not respond differently from untreated controls. Papillomas resulting from treatment with 16 or 64 μg of BAP/wk for 28 wk stained for intracellularly localized TGF-β1 predominantly in the differentiating and nondividing layers. Papillomas stained for extracellularly localized TGF-β1 solely in the less differentiated and dividing cells. These results suggest that tumorigenesis by BAP involves the induction of cumulative changes in epidermal TGF-β1 mRNA and protein concentrations as well as alterations in skin morphology associated with a tumor-promotion process.Keywords
This publication has 36 references indexed in Scilit:
- Stimulation of TGF-β1 mRNA concentration in mouse skin treated with benzo[a]pyreneCarcinogenesis: Integrative Cancer Research, 1992
- TGF‐β1 and skin carcinogenesis: Antiproliferative effect in vitro and TGF‐β1 mRNA expression during epidermal hyperproliferation and multistage tumorigenesisMolecular Carcinogenesis, 1991
- Stimulatory role of transforming growth factors in multistage skin carcinogenesis: Possible explanation for the tumor‐inducing effect of wounding in initiated nmri mouse skinInternational Journal of Cancer, 1989
- Chemical induction of oncogene mutations and growth factor activity in mouse skin carcinogenesis.Environmental Health Perspectives, 1989
- Chemical Induction of Oncogene Mutations and Growth Factor Activity in Mouse Skin CarcinogenesisEnvironmental Health Perspectives, 1989
- Distribution and modulation of the cellular receptor for transforming growth factor-beta.The Journal of cell biology, 1987
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.The Journal of Experimental Medicine, 1986
- Separation of initiating and promoting effects of the skin carcinogen 7-bromomethylbenz(a)anthraceneCarcinogenesis: Integrative Cancer Research, 1980
- The covalent binding of polycyclic hydrocarbons to DNA in the skin of mice of different strainsInternational Journal of Cancer, 1978